Healthcare Industry Updates Healthcare Lab Automation Market | Page 2

The genomics solutions segment to grow at the highest CAGR
Based on applications, the lab automation market is segmented into drug discovery, clinical diagnostics,
genomics solutions, proteomics solutions, microbiology, and other applications. The genomics solutions
segment is expected to grow at the highest CAGR during the forecast period. The use of automation is
on the rise in genomics for high-throughput requirements, providing greater reproducibility and
throughput as compared to manual methods.
Download FREE Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1158
Geographical Analysis:
North America is expected to command the largest share of the global lab automation market in 2017.
The increasing adoption of lab automation systems, implementation of the Affordable Care Act (ACA) in
2010 and economy stimulus programs such as increased funds for the National Institutes of Health (NIH)
and the National Science Foundation (NSF), and increased R&D activities by biotechnology and
pharmaceutical companies are driving growth in the lab automation market in North America.
Key Market Players:
In 2017, Tecan (Switzerland) is expected to dominate the lab automation market. Some of the other
players competing in this market are PerkinElmer (US), Danaher (Beckman Coulter & Molecular Devices)
(US), Thermo Fisher (US), Agilent Technologies (US), Hamilton Robotics (US), Abbot Diagnostics (US),
Eppendorf (Germany), QIAGEN (Netherlands), Roche Diagnostics (Switzerland), and Siemens Healthcare
(Germany).
Request Free Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1158
Lab Automation Market by Equipment and Software (Robotic Arms, Microplate Readers, LIMS),
Applications (Drug Discovery, Clinical Diagnostics, Genomics), End Users (Biotechnology and
Pharmaceuticals, Diagnostic Labs) - Global Forecast to 2022